Department of Social and Preventive Medicine
Research. Populations. Prevention.

Kirsten B. Moysich, PhD
Professor
Department of Cancer Prevention and Control
Roswell Park Cancer Institute           
kirsten.moysich@roswellpark.org
A-316 Carlton House
716-845-8004
716-845-1126 (fax)

Education

BA, Psychology, summa cum laude, State University College of NY at Buffalo, 1992
MS, Epidemiology, University at Buffalo, 1994
PhD, Epidemiology and Community Health, University at Buffalo, 1996

Professional Training
Postdoctoral Fellow, Cancer Epidemiology, Department of Social and Preventive Medicine, University at Buffalo, 1996-1998

Profile
Dr. Moysich joined the staff of Roswell Park Cancer Institute in 1998 and was appointed Full Member in the Department of Cancer Prevention and Control, Roswell Park Cancer Institute in 2009. Dr. Moysich is also Professor in the Department of Cancer Pathology and Prevention, RPCI, and Department of Social and Preventive Medicine at the University at Buffalo.

Research Interests
Dr. Moysich's research interests focus on the role of inflammation in ovarian cancer, radiation exposure and subsequent reproductive health indicators; environmental risk factors for breast cancer; health effects of radiation resulting from the Chernobyl accident.

Selected Publications

  • Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Regular Use of Analgesic Drugs and Ovarian Cancer Risk. Cancer Epidemiology, Biomarkers and Prevention 2001; 10:903-906.
  • Moysich KB, Menezes RJ, Michalek AM. Chernobyl-Related Ionizing Radiation Exposure and Cancer Risk – A Review of the Epidemiological Literature. Lancet Oncology 2002;3:269-279.
  • Moysich KB, Ronsani A, Menezes RJ, Swede H, Reid ME, Falkner KL, Cummings KM, Loewen G, and Bepler G. Regular Aspirin Use and Lung Cancer Risk. BMC Cancer 2002, 2:31.
  • Moysich KB, Menezes RJ, Baker JA, Falkner KL. Environmental Exposure to Polychlorinated Biphenyls and Breast Cancer Risk. Reviews on Environmental Health 2002; 17:249-262.
  • Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Shields PG. Relationships between CYP17, Breast Cancer, and Breast Cancer Risk Factors. Breast Cancer Res 2003, 5:R45-R51.
  • Yang J, Tan DF, Asch HH, Swede H, Bepler G, Geradts J, Moysich KB. Prognostic Significance of Gelsolin Expression in Non-Small Cell Lung Cancer. Lung Cancer. 2004, 46:29-42.
  • Swede H, Mirand AL, Leiras CC, Menezes RJ, Moysich KB. Association of Regular Aspirin Use and Breast Cancer Risk. Oncology 2005;68(1):40-47.
  • Baker JA, Menezes RJ, Weiss JR, Czuczman M, Ambrosone CB, Moysich KB. Analgesic use and risk of non-Hodgkin's lymphoma. Cancer Causes and Control 2005; 16:301-308.

Professional Affiliations
American Association for Cancer Research; American College of Epidemiology; International Society for Environmental Epidemiology; Molecular Epidemiology Group; Women in Cancer Research

Faculty Links

revised 2/4/10

Top of Page ]